Verona, NY, United States of America

Charles A Lawson

This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 1998-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Verona, NY (US) (1998)
  • Verona, NJ (US) (1999)

Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Charles A Lawson

Introduction

Charles A Lawson is a notable inventor based in Verona, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. With a total of 2 patents to his name, Lawson's work is recognized for its innovative approach to healthcare.

Latest Patents

One of Lawson's latest patents is a method of inducing vasorelaxation to treat pulmonary hypertension. This invention provides a method of selectively decreasing pulmonary vascular resistance in a subject by administering endobronchially a drug chosen from among cAMP analogs, cGMP analogs, phosphodiesterase inhibitors, nitric oxide precursors, nitric oxide donors, and nitric oxide analogs. This groundbreaking method has the potential to improve treatment options for patients suffering from this serious condition.

Career Highlights

Lawson is affiliated with Columbia University, where he continues to engage in research and development in his field. His work has not only advanced medical science but has also paved the way for future innovations in pulmonary care.

Collaborations

Throughout his career, Lawson has collaborated with esteemed colleagues such as David J Pinsky and Arthur Smerling. These partnerships have contributed to the success and impact of his inventions.

Conclusion

Charles A Lawson's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving healthcare. His work continues to inspire advancements in the treatment of pulmonary hypertension.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…